Fixed Combination for the Treatment of Dyslipidaemia

PURPOSE OF REVIEW: It is clear from epidemiological studies that patients at high and very-high risk of atherosclerotic cardiovascular diseases (ASCVD) risk do not reach lipid guideline–recommended targets. Thus, fixed-dose combinations of statins/ezetimibe, bempedoic acid/ezetimibe and statins/fibr...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferri, Nicola, Ruscica, Massimiliano, Santos, Raul D., Corsini, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10564832/
https://www.ncbi.nlm.nih.gov/pubmed/37715044
http://dx.doi.org/10.1007/s11883-023-01142-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10564832/
https://www.ncbi.nlm.nih.gov/pubmed/37715044
http://dx.doi.org/10.1007/s11883-023-01142-x

Ejemplares similares